Transdermal Patches Containing Opioids in the Treatment of Patients with Chronic Pain

被引:1
|
作者
De Marco, Iolanda [1 ,2 ]
机构
[1] Univ Salerno, Dept Ind Engn, Via Giovanni Paolo II 132, I-84084 Fisciano, SA, Italy
[2] Univ Salerno, Res Ctr Biomat BIONAM, Via Giovanni Paolo II 132, I-84084 Fisciano, SA, Italy
关键词
fentanyl; buprenorphine; transdermal patches; reservoir and matrix systems; 20; MU-G/H; RELEASE TRAMADOL TABLETS; CHRONIC NONCANCER PAIN; BUPRENORPHINE PATCHES; POSTOPERATIVE PAIN; FENTANYL PATCHES; DELIVERY-SYSTEM; CANCER PAIN; OPEN-LABEL; MATRIX;
D O I
10.3390/pr11092673
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Transdermal delivery is a non-invasive route, used as an alternative to the oral route, to administer drugs through the skin surface. One of the fields in which they are particularly used is that of pain therapy. In this treatment, transdermal patches, particularly those containing opioids, are used to complement or replace orally administered drugs. First-generation patches are constituted by reservoir systems, where the drug is dissolved in a solvent and gelled with a polymer. In contrast, the active principle is incorporated into the polymer adhesive in more recent matrix patches. In this review, the main papers related to the production and employment of transdermal patches containing the two most used opioids, i.e., fentanyl and buprenorphine, have been critically analyzed. From the analysis of the literature, it is possible to deduce that the type of drug and the amount of drug present in the patch must be chosen not according to the origin of the pain but to the age of the patient, the area where the patch is applied, and the frequency at which the patch is replaced.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Transdermal opioids for cancer pain
    Tracy L Skaer
    Health and Quality of Life Outcomes, 4
  • [2] Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study
    Serpell, Mick
    Tripathi, Shiva
    Scherzinger, Sabine
    Rojas-Farreras, Sonia
    Oksche, Alexander
    Wilson, Margaret
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2016, 9 (01) : 35 - 46
  • [3] Opioids Switching with Transdermal Systems in Chronic Cancer Pain
    Aurilio, C.
    Pace, M. C.
    Pota, V.
    Sansone, P.
    Barbarisi, M.
    Grella, E.
    Passavanti, M. B.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [4] Opioids Switching with Transdermal Systems in Chronic Cancer Pain
    C Aurilio
    MC Pace
    V Pota
    P Sansone
    M Barbarisi
    E Grella
    MB Passavanti
    Journal of Experimental & Clinical Cancer Research, 28
  • [5] Practice Guidelines for Transdermal Opioids in Malignant Pain
    Tracy L. Skaer
    Drugs, 2004, 64 : 2629 - 2638
  • [6] Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study
    Mick Serpell
    Shiva Tripathi
    Sabine Scherzinger
    Sònia Rojas-Farreras
    Alexander Oksche
    Margaret Wilson
    The Patient - Patient-Centered Outcomes Research, 2016, 9 : 35 - 46
  • [7] Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain
    Andresen, T.
    Staahl, C.
    Oksche, A.
    Mansikka, H.
    Arendt-Nielsen, L.
    Drewes, A. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (03) : 934 - 945
  • [8] Opioids, sensory systems and chronic pain
    Stein, Christoph
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 716 (1-3) : 179 - 187
  • [9] Treatment of chronic musculoskeletal pain with opioids
    Robert Gasik
    Tadeusz Styczyński
    Clinical Rheumatology, 2008, 27 : 1473 - 1474
  • [10] The application of transdermal buprenorphine in the treatment of chronic cancer pain
    Cialkowska-Rysz, Aleksandra
    Kazmierczak-Lukaszewicz, Sylwia
    Gottwald, Leszek
    MEDYCYNA PALIATYWNA-PALLIATIVE MEDICINE, 2009, 1 (01): : 40 - 44